Page last updated: 2024-09-04

pomalidomide and Carcinoma, Lewis Lung

pomalidomide has been researched along with Carcinoma, Lewis Lung in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anderson, KC; Birsner, AE; D'Amato, RJ; LeBlanc, R; Lentzsch, S; Rogers, MS; Shah, JH; Treston, AM	1

Other Studies

1 other study(ies) available for pomalidomide and Carcinoma, Lewis Lung

Article	Year
S-3-Amino-phthalimido-glutarimide inhibits angiogenesis and growth of B-cell neoplasias in mice. Cancer research, 2002, Apr-15, Volume: 62, Issue:8 Topics: 3T3 Cells; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Burkitt Lymphoma; Carcinoma, Lewis Lung; Cell Division; Growth Inhibitors; Humans; Interleukin-6; Male; Mice; Mice, Inbred C57BL; Mice, SCID; Multiple Myeloma; Neovascularization, Physiologic; Thalidomide; Xenograft Model Antitumor Assays	2002

Article

Year

S-3-Amino-phthalimido-glutarimide inhibits angiogenesis and growth of B-cell neoplasias in mice.

Cancer research, 2002, Apr-15, Volume: 62, Issue:8

Topics: 3T3 Cells; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Burkitt Lymphoma; Carcinoma, Lewis Lung; Cell Division; Growth Inhibitors; Humans; Interleukin-6; Male; Mice; Mice, Inbred C57BL; Mice, SCID; Multiple Myeloma; Neovascularization, Physiologic; Thalidomide; Xenograft Model Antitumor Assays

2002